Cargando…

Targeted kinase inhibition relieves slowness and tremor in a Drosophila model of LRRK2 Parkinson’s disease

In a number of Drosophila models of genetic Parkinson’s disease (PD) flies climb more slowly than wild-type controls. However, this assay does not distinguish effects of PD-related genes on gravity sensation, “arousal”, central pattern generation of leg movements, or muscle. To address this problem,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cording, Amy C., Shiaelis, Nicolas, Petridi, Stavroula, Middleton, C. Adam, Wilson, Laurence G., Elliott, Christopher J. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715132/ https://www.ncbi.nlm.nih.gov/pubmed/29214211 http://dx.doi.org/10.1038/s41531-017-0036-y

Ejemplares similares

In Vivo Visual Screen for Dopaminergic Rab ↔ LRRK2-G2019S Interactions in Drosophila Discriminates Rab10 from Rab3
por: Petridi, Stavroula, et al.
Publicado: (2020)

Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson’s disease
por: Lin, Yu-En, et al.
Publicado: (2021)

Dopa Responsive Slow Orthostatic Tremor in Parkinson’s Disease
por: Lee, Suk Yoon, et al.
Publicado: (2011)

Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease
por: Gonzalez-Hunt, C. P., et al.
Publicado: (2020)

Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2
por: Deng, Xianming, et al.
Publicado: (2011)

Case-control analysis of LRRK2 protective variants in Essential Tremor
por: Ng, Adeline S. L., et al.
Publicado: (2018)

Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
por: Smith, G. A., et al.
Publicado: (2015)

Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
por: Purlyte, Elena, et al.
Publicado: (2017)

Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010)

A Slow Orthostatic Tremor of Primary Origin
por: Coffeng, Sophie M., et al.
Publicado: (2013)

Parkinson’s tremor
por: Elias, Jeff, et al.
Publicado: (2015)

Levodopa-Responsive Primary Slow Orthostatic Tremor: A Premotor Sign of Parkinson's Disease?
por: Yoshii, Fumihito, et al.
Publicado: (2020)

Slow Orthostatic Tremor and the Case for Routine Electrophysiological Evaluation of All Tremors
por: Torres-Russotto, Diego, et al.
Publicado: (2019)

Multiple Pathways of LRRK2-G2019S/Rab10 Interaction in Dopaminergic Neurons
por: Fellgett, Alison, et al.
Publicado: (2021)

Isolated slow orthostatic tremor of the trunk
por: Aziz, N. Ahmad, et al.
Publicado: (2022)

LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
por: Galper, Jasmin, et al.
Publicado: (2022)

Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons
por: Wang, Danling, et al.
Publicado: (2008)

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
por: Steger, Martin, et al.
Publicado: (2016)

Lrrk2 R1628P variant is a risk factor for essential tremor
por: Chao, Yin Xia, et al.
Publicado: (2015)

The Clinical Evaluation of Parkinson’s Tremor
por: Zach, Heidemarie, et al.
Publicado: (2015)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

Dystonia Associated with Idiopathic Slow Orthostatic Tremor
por: Kobylecki, Christopher, et al.
Publicado: (2016)

Slow Orthostatic Tremor: Review of the Current Evidence
por: Hassan, Anhar, et al.
Publicado: (2019)

Steam Train Sign in Slow Orthostatic Tremor
por: Swinnen, Bart E.K.S., et al.
Publicado: (2022)

Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
por: Rudenko, Iakov N, et al.
Publicado: (2012)

Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity
por: Shu, Yang, et al.
Publicado: (2016)

Linking the scaling of tremor and slow slip near Parkfield, CA
por: Huang, Hui, et al.
Publicado: (2022)

Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2(WD40) Genetic Model of Parkinson’s Disease
por: Casu, Maria Antonietta, et al.
Publicado: (2020)

LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
por: Taymans, Jean-Marc, et al.
Publicado: (2011)

A leucine‐rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls
por: Vissers, Maurits F. J. M., et al.
Publicado: (2023)

A Slow Axon Antidromic Blockade Hypothesis for Tremor Reduction via Deep Brain Stimulation
por: García, Míriam R., et al.
Publicado: (2013)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm, Farzaneh, et al.
Publicado: (2016)

Re-Emergent Tremor of Parkinson’s Disease Masquerading as Essential Tremor
por: Morgan, Sarah, et al.
Publicado: (2016)

Prevalence and Relationship of Rest Tremor and Action Tremor in Parkinson’s Disease
por: Gupta, Deepak K., et al.
Publicado: (2020)

Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson’s disease and beyond
por: Bae, Jae Ryul, et al.
Publicado: (2015)

Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding
por: Kalogeropulou, Alexia F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a27pbjhcsj69kkdd9d2c5svn0m